CLINICAL_TRIALS
research
· 2015-06-23
Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
Summary
The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in ovarian cancer and …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: OvaGene Oncology, Inc. | Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms | Status: UNKNOWN